NCT06441474View on ClinicalTrials.gov

Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information in Women

PHASE2RecruitingINTERVENTIONAL
Enrollment

750

Participants

Timeline

Start Date

April 2, 2025

Primary Completion Date

April 2, 2027

Study Completion Date

April 2, 2028

Conditions
Breast Cancer Female
Interventions
BEHAVIORAL

Presentation of personal breast cancer risk estimate

All participants will be presented with their personal breast cancer risk estimate, calculated using the Gail Model

Trial Locations (2)

63130

RECRUITING

Washington University in St. Louis, St Louis

80045

RECRUITING

University of Colorado Denver, Aurora

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

National Institutes of Health (NIH)

NIH

lead

University of Colorado, Denver

OTHER